D
Dirk Bassler
Researcher at Boston Children's Hospital
Publications - 5
Citations - 470
Dirk Bassler is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Randomized controlled trial & Systematic review. The author has an hindex of 5, co-authored 5 publications receiving 437 citations.
Papers
More filters
Journal ArticleDOI
Early interventions involving parents to improve neurodevelopmental outcomes of premature infants: a meta-analysis
Jessica A. Vanderveen,Jessica A. Vanderveen,Dirk Bassler,Charlene M.T. Robertson,Haresh Kirpalani,Haresh Kirpalani +5 more
TL;DR: Positive clinically meaningful effects are seen to the age of 36 months, but are no longer present at 5 years.
Journal ArticleDOI
Probiotics Reduce the Risk of Necrotizing Enterocolitis in Preterm Infants: A Meta-Analysis
TL;DR: Enteral supplementation of probiotics reduces the risk of severe NEC and mortality in preterm infants and a large randomized controlled trial is required to investigate the benefit and safety profile of probiotic supplementation in ELBW infants.
Journal ArticleDOI
LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact
Elie A. Akl,Matthias Briel,Matthias Briel,John J. You,Francois Lamontagne,Francois Lamontagne,Azim S. Gangji,Tali Cukierman-Yaffe,Mohamad Alshurafa,Xin Sun,Xin Sun,Kara Nerenberg,Bradley C. Johnston,Claudio Vera,Edward J Mills,Dirk Bassler,Arturo Salazar,Neera Bhatnagar,Jason W. Busse,Zara Khalid,Stephen D. Walter,Deborah J. Cook,Holger J. Schünemann,Douglas G. Altman,Gordon H. Guyatt +24 more
TL;DR: A systematic review of reports of RCTs recently published in five top general medical journals to assess the potential impact of loss to follow-up on the estimates of treatment effect and the mean change in effect estimate is calculated.
Journal ArticleDOI
Choice of data extraction tools for systematic reviews depends on resources and review complexity.
Mohamed B. Elamin,David N. Flynn,Dirk Bassler,Matthias Briel,Matthias Briel,Pablo Alonso-Coello,Paul J. Karanicolas,Gordon H. Guyatt,Germán Málaga,Toshiaki A. Furukawa,Regina Kunz,Holger J. Schünemann,Mohammad Hassan Murad,Corrado Barbui,Andrea Cipriani,Victor M. Montori +15 more
TL;DR: In this article, the authors present an initial table listing available data-collection tools and reflect their experience with these tools and their performance, and an international group of experts iteratively reviewed the table and reflected on the performance of the tools until no new insights and consensus resulted.
Journal ArticleDOI
Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).
Matthias Briel,Matthias Briel,Melanie A. Lane,Victor M. Montori,Dirk Bassler,Paul Glasziou,Germán Málaga,Elie A. Akl,Ignacio Ferreira-González,Pablo Alonso-Coello,Gerard Urrútia,Regina Kunz,Carolina Ruiz Culebro,Suzana A. Silva,David N. Flynn,Mohamed B. Elamin,Brigitte Strahm,M. Hassan Murad,Benjamin Djulbegovic,Neill K. J. Adhikari,Edward J Mills,Femida Gwadry-Sridhar,Haresh Kirpalani,Haresh Kirpalani,Heloisa P. Soares,Nisrin O. Abu Elnour,John J. You,Paul J. Karanicolas,Heiner C. Bucher,Julianna F. Lampropulos,Alain J Nordmann,Karen E. A. Burns,Sohail M. Mulla,Heike Raatz,Amit Sood,Jagdeep Kaur,Clare Bankhead,Rebecca J. Mullan,Kara Nerenberg,Per Olav Vandvik,Fernando Coto-Yglesias,Holger J. Schünemann,Fábio Antônio Abrantes Tuche,Pedro Paulo M. Chrispim,Deborah J. Cook,Kristina Lutz,Christine Ribic,Noah Vale,Patricia J. Erwin,Rafael Perera,Qi Zhou,Diane Heels-Ansdell,Tim Ramsay,Stephen D. Walter,Gordon H. Guyatt +54 more
TL;DR: A better understanding of the extent to which tRCTs exaggerate treatment effects and of the factors associated with the magnitude of this bias can optimize trial design and data monitoring charters, and may aid in the interpretation of the results from trials stopped early for benefit.